MicuRx Raises $25 Mln
MicuRx Pharmaceuticals said Thursday it raised $25 million in Series B financing led by BVCF. The round also includes existing investors Morningside Group and Devon Park Bioventures. Hayward, Calif.-based MicuRx is a biopharmaceutical company developing next-generation antibiotics.
22 August 2013•3 mins read
